“Humoral and Cellular BNT162b2 MRNA-Based Booster Vaccine-Induced Immunity in Patients With Multiple Myeloma and Persistence of Neutralising Antibodies: Results of a Prospective Single-Centre Cohort Study”. Swiss Medical Weekly 153, no. 6 (June 15, 2023): 40090. Accessed November 5, 2025. https://smw.ch/index.php/smw/article/view/3346.